In contrast, combined therapy (CAI + DMF or CAI + 1-MT) significantly reduced the expression of PD-1+ in CD45.1+ T cells and clearly inhibited tumor growth (Fig. 5g~i). The gene discussed is PDCD1; the disease is neoplasm.